What is the current inventory status of epidemic prevention products? Plans to open offline stores this year? Robust medical response

Gelonghui, May 10 | On “Current Inventory Status of Epidemic Prevention Products?” Problem, Robust Healthcare recently stated at a performance briefing that in 2023, the company took various measures and carried out extensive work around reducing production capacity, removing inventory, restructuring, and reducing value. Up to now, the vast majority of inventory and remaining issues of epidemic prevention products have been resolved. Currently, infection protection products are mainly sold with flat masks. There is still normal demand in the market, and the business base still exists. From a profit level perspective, the gross margin of infection protection products is definitely lower than in 2023. However, the company continues to improve the level of automation through product innovation, cost reduction and efficiency

Gelonghui FinanceMay 10 10:08

Express News | Robust healthcare: maintain the pace of opening around 100 stores every year in the cotton era for the next 3-5 years

BreakingsMay 10 09:46

Steady Healthcare (300888.SZ) received a total increase of 1391,000 shares from a number of directors and supervisors

Robust Healthcare (300888.SZ) announcement, company director, deputy general manager and financial director Fang Xiuyuan, director Xu Xiaodan...

Zhitong FinanceMay 6 20:06

Robust Healthcare (300888.SZ): Repurchase completed, 0.987% of shares have been repurchased

Gelonghui, May 6, 丨 Robust Healthcare (300888.SZ) announced that as of April 29, 2024, the company had repurchased 5,807,900 shares of the company through a dedicated securities account, accounting for 0.9872% of the company's total share capital. The highest transaction price was 39.79 yuan/share, the minimum transaction price was 29.25 yuan/share, and the total transaction amount was 195 million yuan (excluding transaction fees). The implementation of this share repurchase plan has been completed.

Gelonghui FinanceMay 6 19:05

Steady Healthcare (300888): Multi-channel deep collaboration to grow beautifully in the consumer goods business

Guide to this report: The pressure on the company's 2023 performance was mainly affected by the decline in demand for infection protection products, but the consumer goods business still achieved steady growth. It is expected that along with the optimization of store floor efficiency, the performance is expected to grow steadily. Investment Highlights: Conclusion: Consider the Public

國泰君安May 5 15:31

Steady Healthcare (300888): Cotton brands show resilience in stabilizing, moderating, and improving routine medical business

Performance summary: The company released its 2023 annual report and 2024 quarterly report. In 2023, the company achieved revenue of 8.19 billion yuan, -27.9% year on year; realized net profit of 580 million yuan, -64.8% year on year; realized deductions

西南證券May 1 00:00